Character | No. (%) of TB cases | Successful outcome, n (%) | COR (95% CI) | P-value | AOR (95%CI) | P-value |
---|---|---|---|---|---|---|
Sex | ||||||
 Male | 237 (46.01) | 201 (84.81) | 0.08 (0.48–1.32) | 0.39 | 0.93 (0.53–1.63) | 0.81 |
 Female | 278 (53.99) | 243 (87.41) | 1.00 |  | 1.00 |  |
Age | ||||||
 0–20 | 185 (35.92) | 165 (89.19) | 3.34 (1.61–6.93) | 0.001 | 3.47 (1.54–7.81) | 0.003 |
 21–40 | 189 (36.69) | 165 (87.30) | 2.78 (1.37–5.65) | 0.005 | 2.76 (1.26–6.03) | 0.011 |
 41–60 | 82 (15.92) | 72 (87.80) | 2.91 (1.22–6.95) | 0.016 | 2.82 (1.08–7.35) | 0.034 |
 ≥ 61 | 59 (11.45) | 42 (71.18) | 1.00 |  | 1.00 |  |
TB form | ||||||
 Smear positive PTB | 252 (48.93) | 232 (92.06) | 2.88 (1.605–5.16) | 0.000 | 3.58 (1.89–6.78) | < 0.001 |
 Sear negative PTB | 82 (15.92) | 67 (81.70) | 1.11 (0.57–2.16) | 0.762 | 1.18 (0.56–2.48) | 0.650 |
 EPTB | 181 (35.15) | 145 (80.11) | 1.00 |  | 1.00 |  |
Patient category | ||||||
 New | 493 (95.72) | 426 (86.40) | 0.57 (0.07–4.55) | 0.603 | 0.57 (0.07–4.55) | 0.603 |
 Relapse | 10 (1.94) | 7 (70.00) | 0.21 (0.02–2.46) | 0.215 | 0.21 (0.02–2.46) | 0.215 |
 Other | 12 (2.33) | 11 (91.67) | 1.00 |  | 1.00 |  |
Treatment category | ||||||
 Category I | 503 (97.66) | 437 (86.87) | 0.21 (0.06–0.68) | 0.01 | 4.71 (1.17–18.97) | 0.029 |
 Category II | 12 (2.33) | 7 (58.33) | 1.00 |  | 1.00 |  |
Year of treatment | ||||||
 2011 | 116 (22.52) | 101 (87.06) | 2.37 (1.24–4.54) | 0.009 | 2.42 (1.22–4.82) | 0.012 |
 2012 | 118 (22.91) | 112 (94.91) | 6.58 (2.69–16.09) | 0.000 | 6.26 (2.52–15.59) | < 0.001 |
 2013 | 120 (23.30) | 112 (93.33) | 4.94 (2.22–10.98) | 0.000 | 4.31 (1.88–9.86) | < 0.001 |
 2014 | 161 (31.26) | 119 (73.91) | 1.00 |  | 1.00 |  |